Photo Credit: Allogene Therapeutics. Image of the ALLO-316 allogeneic CAR-T cell therapy. The California Institute for Regenerative Medicine (CIRM) awarded $15 million to Dr. John Le Gall and his team at Allogene Therapeutics. This funding will support the development of ALLO-316, an innovative anti-CD70 CAR-T cell product designed to treat metastatic clear cell renal cell … Continue reading Supporting a CAR-T cell trial for kidney cancer
stem cell research
CIRM’s $31 million boost for cancer and eye disease research
The California Institute for Regenerative Medicine (CIRM) recently approved nearly $31 million in funding, further cementing our commitment to advancing the field of regenerative medicine. This substantial investment aims to drive clinical research targeting various cancers and eye diseases. CIRM’s dedication to fostering innovative treatments is demonstrated through its clinical program, which funds eligible stem … Continue reading CIRM’s $31 million boost for cancer and eye disease research
Mental Health Awareness Month: How CIRM is advancing research for neuropsychiatric disorders
Since 1949, Mental Health Awareness Month has been observed in May each year to increase awareness of the importance of mental health and wellness in America. In California, it is estimated that 1.2 million adults have a serious mental illness and that 5.6 million adults have a mental health condition. Today, neuropsychiatric disorders continue to … Continue reading Mental Health Awareness Month: How CIRM is advancing research for neuropsychiatric disorders
CIRM at LABEST: Empowering the future of bioscience in the LA region
The California Institute for Regenerative Medicine (CIRM) proudly participated in and sponsored the recent 2024 Los Angeles Bioscience Ecosystem Summit Twenty (LABEST) Conference, the premier showcase for bioscience innovation in Los Angeles. With around 1,000 participants, LABEST is one of the largest gatherings of visionary scientists, enthusiastic entrepreneurs, and pioneering institutions in the region. Top … Continue reading CIRM at LABEST: Empowering the future of bioscience in the LA region
CIRM invests $1.5 million to UCLA for research identifying risk factors for viral infections
Image of Michael Wells, PhD from UCLA The California Institute for Regenerative Medicine (CIRM) recently awarded $1.5 million to a new research project led by Michael Wells, PhD, of UCLA, that aims to identify the genetic and molecular risk factors underlying disease-causing viral infections in multiple diverse ancestral populations. Dr. Wells and his team of … Continue reading CIRM invests $1.5 million to UCLA for research identifying risk factors for viral infections
Equipping California nurses with skills to support cell and gene therapy patients
Regenerative medicine is a rapidly evolving field. As more therapies reach commercialization and clinical trial stages, there remains an immediate need to equip direct patient care nurses with skills to support patients on complex clinical trials as well as novel standard-of-care therapies. To address this need and continue efforts to build a regenerative medicine workforce … Continue reading Equipping California nurses with skills to support cell and gene therapy patients
CIRM awards $25 million for discovery and clinical research, infrastructure programs
Stock image of a researcher The California Institute for Regenerative Medicine (CIRM) has recently approved awarding $25 million to fund multiple projects across discovery research, clinical research, and infrastructure programs.This funding will support 11 projects under CIRM's Foundation Awards Program, which aims to drive rigorous studies addressing critical basic knowledge gaps in the biology of … Continue reading CIRM awards $25 million for discovery and clinical research, infrastructure programs
State agency launches ‘Championing Change for Sickle Cell in California’ campaign
The California Institute for Regenerative Medicine (CIRM), established by the voters of California, is accelerating research and awareness of Sickle Cell Disease. The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, is proud to announce the launch of "Championing Change for Sickle Cell in California,” a pioneering … Continue reading State agency launches ‘Championing Change for Sickle Cell in California’ campaign
Igniting innovation: How CIRM is bringing new and diverse perspectives in regenerative medicine
CIRM has produced videos highlighting the experiences of participants from our educational and training programs. At the California Institute for Regenerative Medicine (CIRM), we are passionate about catalyzing growth in regenerative medicine while championing inclusivity. One of CIRM’s strategic goals is to build a diverse and skilled workforce that represents the rich tapestry of California's … Continue reading Igniting innovation: How CIRM is bringing new and diverse perspectives in regenerative medicine
Advancing Clinical Research for a CAR T-Cell Therapy for Systemic Lupus Erythematosus (SLE), Autoimmune Diseases
Symptoms of lupus may include pain or swelling in the joints, extreme fatigue, a butterfly rash on the cheeks and nose, and more. The California Institute for Regenerative Medicine (CIRM) has awarded $7.9 million to Barbara Hickingbottom, MD, of Fate Therapeutics to advance clinical research for FT819, an induced pluripotent stem cell (iPSC)-derived CD19 CAR … Continue reading Advancing Clinical Research for a CAR T-Cell Therapy for Systemic Lupus Erythematosus (SLE), Autoimmune Diseases